Charles River Laboratories CRL Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $4.02B-0.9% | $4.05B-1.9% | $4.13B+3.9% | $3.98B+12.3% | ||
| $743.07M-1.1% | $751M+0.4% | $747.86M+12.4% | $665.1M+7.3% | ||
| —— | —— | $617.26M-5.2% | $650.98M+10.4% | ||
| $107.03M-15.3% | $126.29M-7.6% | $136.71M+131% | $59.29M-19.8% | ||
| —— | -$16.52M-117% | $95.54M+213% | $30.52M+180% | ||
| —— | $70.87M-29.8% | $100.91M-22.6% | $130.38M+59.2% | ||
| -$144.34M— | —— | $474.62M-2.4% | $486.23M+24.4% | ||
| -3.6%— | —— | 11.5%-0.7pp | 12.2%+1.2pp | ||
| -$2.90— | —— | $9.23-2.5% | $9.47+24.6% | ||
| $710.81M-12.1% | $808.29M-13.2% | $931.39M-2.5% | $954.85M+11.6% | ||
| 17.7%-2.3pp | 20%-2.6pp | 22.6%-1.5pp | 24%-0.1pp | ||
| $307.5M-31.1% | $446.55M-27.7% | $617.26M-5.2% | $650.98M+10.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Charles River Laboratories's revenue?
- Charles River Laboratories (CRL) generated $4.0B in revenue over the trailing twelve months, up 0.1% year over year.
- Is Charles River Laboratories profitable?
- Charles River Laboratories is not currently profitable: it reported a net loss of $184.7M over the trailing twelve months, a -4.6% net margin.
- What are Charles River Laboratories's profit margins?
- Gross margin is 84.7% and operating margin is 13.0%, with a -4.6% net margin.
- What is Charles River Laboratories's earnings per share?
- Charles River Laboratories's diluted EPS over the trailing twelve months is $-3.70.
- Where does Charles River Laboratories's income statement data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
